Omics disciplines such as metabolomics, lipidomics, and proteomics offer a wide range of applications in the cosmetics industry, driving innovation and personalization in product development. These omics applications are revolutionizing the cosmetics industry, enabling the development of more effective, safe, and personalized products tailored to consumers’ specific needs.
Lipid biomarkers for skin health:
Identifying lipids as indicators of hydration, elasticity, and aging.
Skin barrier studies:
Analyzing skin lipids to understand and improve the skin’s barrier function.
Advanced formulation design:
Developing cosmetic products aimed at restoring lipid balance in dry, oily, or aging skin.
Research on skin disorders:
Studying the role of lipids in conditions such as dermatitis, psoriasis, or acne to create targeted solutions.
Biomarker discovery:
Detecting metabolites that indicate skin damage, oxidative stress, or inflammation to enhance product efficacy.
Skin analysis:
Identify metabolite signatures associated with skin aging, hydration status, and other skin phenotypes to support product development.
Efficacy assessment:
Analyzing metabolic changes induced by cosmetics to measure their impact on skin health.
Personalized product development:
Designing products tailored to individual metabolic profiles for optimal results and minimal adverse reactions.
Skin aging analysis:
Identify protein signatures associated with skin aging to support product development and performance evaluation.
Oxidative damage assessment:
Detecting protein markers of oxidative stress in the skin to formulate antioxidant products.
Design of topical actives:
Develop and evaluate topical active candidates (e.g., peptides, recombinant proteins) to assess effects on skin barrier and hydration status in controlled studies.
Skin regeneration studies:
Understanding cellular repair mechanisms and promoting the production of key proteins like collagen and elastin.
At oloBion, we provide cutting-edge omics services designed to empower researchers in the Cosmetics & Dermatology industry. With our state-of-the-art technology and the expertise of our team, we help you unlock the full potential of your analytes, driving discovery, innovation, and impactful solutions. Our portfolio includes both Untargeted and Targeted metabolomics, lipidomics and proteomics services, as well as ADME-DMPK assays, all tailored to meet the specific needs of your research.
Technique: LC-MS/MS
Untargeted lipidomics analysis for the identification of lipids by LC-MS/MS.The Identification includes a list with superclass, class, lipid name, and InChIKey.
Technique: LC-MS/MS
Untargeted lipidomics analysis for the identification of short chain fatty acids by LC-MS/MS. The indentification includes a list with superclass, class, lipid name, and InChIKey.
Technique: LC-MS/MS
Untargeted lipidomics analysis for the identification of lipids by LC-MS/MS, including oxylipins. The Identification includes a list with superclass, class, lipid name, and InChIKey.
Technique: LC-MS/MS
Untargeted lipidomics analysis for the identification of lipids by LC-MS/MS.The Identification includes a list with superclass, class, lipid name, and InChIKey.
Pharmacolipidomics analysis to identify key lipid classes and determine lipid biomarkers related to bioavailability, metabolism, and compound response, supporting ADME and mechanistic evaluation in preclinical studies.
Targeted lipidomics analysis for the quantification of total fatty acids (FW) (g/100g)
Technique: LC-MS/MS
Target Lipidomics analysis for the identification of specific lipid(s) according to customer requirements
Technique: LC-MS/MS
NextGen proteomics analysis by LC-MS/MS for the identification of proteins. The identification includes the family and name of the protein.
Technique: LC-MS/MS
NextGen proteomics analysis by LC-MS/MS for the identification of proteins. The identification includes the family and name of the protein.
Pharmacoproteomics analysis to identify key proteins and determine proteomic biomarkers related to drug metabolism, transport, and resistance mechanisms, supporting mechanistic insight in preclinical research.
Technique: LC-MS/MS
Target Proteomics analysis for the identification of specific protein(s) according to customer requirements
Pharmacoproteomics analysis to identify key proteins and determine proteomic biomarkers related to drug metabolism, transport, and resistance mechanisms, supporting mechanistic insight in preclinical research.
Pharmacolipidomics analysis to identify key lipid classes and determine lipid biomarkers related to bioavailability, metabolism, and compound response, supporting ADME and mechanistic evaluation in preclinical studies.
Pharmacometabolomics studies to identify key metabolic pathways and determine metabolomic biomarkers associated with compound exposure and metabolic response, supporting ADME and mechanistic insight in preclinical research.
Transform your omics data into actionable insights with oloMAP Portal, our interactive platform for advanced statistical analysis and visualization.
Combine multiple omics datasets to uncover relationships between biological layers, gain a holistic view of underlying processes and identify potential biomarkers.
Comprehensive biological interpretation from our experts to connect omics data with biological pathways, highlighting relevant mechanisms and potential biomarkers tailored to your study.
01
Contact and
Proposal
02
Send Samples
to the Lab
03
Sample Reception
and Processing
04
Mass Spectrometry
Analysis
05
Gain Insight into
oloMAP Portal
Standard Delivery Time:
6 weeks
Fast-track option available
Minimum Sample Amount:
Consult our experts for guidance
on sample requirements
Discount:
Associated with the number of
samples and multi-omics analysis
Partner with us to explore the power of our analysis in your field. Our team is ready to guide you through the process and deliver insights tailored to your research or industry needs.
Contact us today to discuss your project or schedule a consultation. Together, we’ll advance innovation through omics!